US Patent Issued to Lee Moffitt Cancer Center and Research Institute on March 3 for "Small molecules against cereblon to enhance effector T cell function" (Florida Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,583, issued on March 3, was assigned to Lee Moffitt Cancer Center and Research Institute Inc. (Tampa, Fla.).

"Small molecules against cereblon to enhance effector T cell function" was invented by Pearlie Burnette (Tampa, Fla.), Harshani Lawrence (Tampa, Fla.) and Nicholas J. Lawrence (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are small molecules against cereblon to enhance effector T cell function. Methods of making these molecules and methods of using them to treat various disease states are also disclosed."

The patent was filed on June 7, 2022, under Application No. 17/834,380.

*For further information, including image...